News | December 06, 2025
Briefs: IOL Chemicals & Pharmaceuticals, Ipca Laboratories and Anuh Pharma
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023
The company will submit its comprehensive response on these observations to the USFDA
The company will submit its comprehensive response on these observations to the US FDA
The company has extended its full co-operation and support to the officials of the Income Tax Department
The company will submit its comprehensive response on these observations to the US FDA within the stipulated time
The business and product range of Ipca and that of Unichem complements each others business and product range
Ipca Laboratories now holds 58.88% of the paid-up equity share capital of the company.
The company has reported total income of Rs. 1607.85 crores during the period ended June 30, 2022.
Subscribe To Our Newsletter & Stay Updated
